SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-032669
Filing Date
2023-09-20
Accepted
2023-09-20 16:39:56
Documents
16
Period of Report
2023-09-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20230920.htm   iXBRL 8-K 34351
2 EX-99.1 aquestivepressreleaseana.htm EX-99.1 10793
6 aquestivepressreleaseana001.jpg GRAPHIC 324135
7 aquestivepressreleaseana002.jpg GRAPHIC 429854
8 aquestivepressreleaseana003.jpg GRAPHIC 45100
  Complete submission text file 0001628280-23-032669.txt   1283425

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20230920.xsd EX-101.SCH 1895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20230920_lab.xml EX-101.LAB 24833
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20230920_pre.xml EX-101.PRE 13039
10 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20230920_htm.xml XML 2818
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 231266910
SIC: 2834 Pharmaceutical Preparations